Nanomaterials in the Management of Gram-Negative Bacterial Infections [PDF]
The exploration of multiplexed bacterial virulence factors is a major problem in the early stages of Escherichia coli infection therapy. Traditional methods for detecting Escherichia coli (E.
Mahmood Barani +8 more
doaj +4 more sources
Sepsis patients with first and second-hit infections show different outcomes depending on the causative organism [PDF]
Objective. With improving rates of initial survival in severe sepsis, second-hit infections that occur following resolution of the primary insult carry an increasing burden of morbidity.
Matthew eMorgan +9 more
doaj +4 more sources
Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
Drug-resistant Gram-negative bacterial pathogens are an increasingly serious health threat causing worldwide nosocomial infections with high morbidity and mortality.
Panagiotis Zagaliotis +3 more
doaj +3 more sources
Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections [PDF]
Infections caused by MBL-producing Gram-negative bacterial pathogens have disseminated worldwide and are associated with considerable morbidity and mortality.
Matthew E. Falagas +3 more
doaj +2 more sources
Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis- [PDF]
BACKGROUND: Gram negative infection is a major determinant of morbidity and survival. Traditional teaching suggests that burn wound infections in different centres are caused by differing sets of causative organisms.
AC Gales +54 more
core +9 more sources
Characteristics and risk factors of secondary bacterial infections in COVID-19 patients
Objective: To describe the characteristics and find out risk factors of COVID-19 patients infected with different categories of bacteria. Design: Case-control.
Guangjie Wu +3 more
doaj +1 more source
Netilmicin in Gram-Negative Bacterial Infections [PDF]
Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%.
D R, Snydman +4 more
openaire +2 more sources
Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections
The multidrug-resistant Gram-negative bacteria (MDR-GNB) infections in severely infected patients present numerous difficulties in terms of treatment failure where antibiotics cannot arrest such drug resistant bacteria.
Wardah Mohammad Akram +4 more
doaj +1 more source
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections
The emergence of infections by carbapenem resistant Enterobacteriaceae (CRE) pathogens has created an urgent public health threat, as carbapenems are among the drugs of last resort for infections caused by a growing fraction of multi-drug resistant (MDR)
Justin B. Schaal +9 more
doaj +1 more source
Increased rate of multidrug-resistant gram-negative bacterial infections in hospitalized immunocompromised pediatric patients [PDF]
Ghassan Dbaibo
exaly +2 more sources

